Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication

PF614, a novel trypsin activated abuse protection (TAAP) prodrug of oxycodone, is being studied as chronic pain analgesic with extended release and abuse resistant properties. A series of nonclinical safety studies were conducted to support PF614 introduction to clinical trials. Ames assays (PF614 and its metabolites), comet assay (PF614 ≤ 50 mg/kg/day oral gavage in rats) and micronucleus assay (PF614 ≤ 175 mg/kg/day oral gavage in rats) were negative. hERG assay IC₅₀ for PF614 was ≥300 μM. PF614 (0.1 and 10 μM) showed a low permeability in Caco-2 cells (≤1.17 x 10-6 cm/s) and was not a P-gp or BCRP substrate or inhibitor. The mean percent unbound PF614 among all concentrations in plasma ranged from 91.2 to 98.4, 79.4 to 100, and 52.9-79.9% in rat, dog, and human, respectively. Also, PF614 was metabolically stable in rat, dog, and human hepatocytes with no metabolites identified. Safety pharmacology study in dog indicated moderately lower heart rate at ≥ 2 mg/kg oral gavage doses. Toxicity studies of PF614 in rat and dog with daily oral doses of 25 and 18 mg/kg, respectively, for 14 Days were well tolerated with favorable safety profile supporting its further clinical evaluation.

Severe Sub-Acromial Bursitis with Rice Bodies in a Patient with Rheumatoid Arthritis: A Case Report and Review of Literature

Multiple rice body formation is a rare presentation of chronic sub-acromial bursitis secondary to extensive underlying rheumatoid arthritis, sero-negative inflammatory arthritis or tuberculous joints. Although there is usually an accompanying inflammatory arthropathy, it can occur in the absence of any underlying systemic disorder. We report a case of five years old neglected rice body deposition in shoulder in a 54-years old lady diagnosed to be having rheumatoid arthritis. After initial investigations, arthroscopic removal of rice bodies with bursa excision relieved the symptoms. The underlying rheumatic condition continued its course, generally sparing the involved shoulder joint. We suggest thorough examination for systemic rheumatologic disease in patients diagnosed with such lesions.

2-Deoxy-d-Glucose (2-DG)-Induced Cardiac Toxicity in Rat: NT-proBNP and BNP as Potential Early Cardiac Safety Biomarkers

2-Deoxy-d-glucose (2-DG) is being developed as a potential anticonvulsant and disease-modifying agent for patients with epilepsy; however, during preclinical development, cardiac toxicity has been encountered in rats. This study was performed to determine whether cardiac troponin (cTnI and cTnT), atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and/or creatine kinase (CK) could be useful as indicators of 2-DG cardiac toxicity. In addition, this study also investigated the association of cardiac histopathological changes with these biomarkers. F344 rats (4/sex/group/sacrifice point) were gavaged with either vehicle or 2-DG (50, 125, or 375 mg/kg twice daily; total daily dose of 100, 250, or 750 mg/kg/d) for 7, 14, 21, or 45 days followed by a 15-day recovery. Dose-dependent increases in NT-proBNP and BNP plasma concentrations were observed. Following recovery period, the NT-proBNP and BNP concentrations returned to baseline levels. There were no remarkable increases in CK, ANP, cTnI, or cTnT concentrations. There were no gross cardiac lesions observed at the necropsy. Microscopic findings of vacuolar degeneration and hypertrophy of the endothelial cells of the endocardium were present in the heart at doses of 250 and 750 mg/kg/d. Microscopic findings, in general, were associated with increases in NT-proBNP levels. Cardiac toxicity appeared to be reversible. In conclusion, NT-proBNP and BNP are potential early biomarkers for 2-DG-induced cardiac toxicity that can be useful to monitor 2-DG therapy in clinical trials.

Targeting activation-induced cytidine deaminase overcomes tumor evasion of immunotherapy by CTLs

Activation-induced cytidine deaminase (AID) is an enzyme essential for the generation of Ab diversity in B cells and is considered to be a general gene mutator. In addition, AID expression was also implicated in the pathogenesis of human B cell malignancies and associated with poor prognosis. In this study, we report that small interfering RNA silencing of AID in plasmacytoma dramatically increased its susceptibility to immunotherapy by CTLs. AID silencing did not decrease the mutation frequencies of tumor Ag gene P1A. Gene-array analysis showed dramatically altered expression of a number of genes in AID-silenced plasmacytoma cells, and upregulation of CD200 was shown to be in favor of tumor eradication by CTLs. Taken together, we demonstrate a novel function of AID in tumor evasion of CTL therapy and that targeting AID should be beneficial in the immunotherapy of AID-positive tumors.

Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy

Tumor evasion of T-cell immunity remains a significant obstacle to adoptive T-cell therapy. It is unknown whether the mode of immune evasion is dictated by the cancer cells or by the tumor antigens. Taking advantage of the fact that multiple lineages of tumor cells share the tumor antigen P1A, we adoptively transferred transgenic T cells specific for P1A (P1CTL) into mice with established P1A-expressing tumors, including mastocytoma P815, plasmocytoma J558, and fibrosarcoma Meth A. Although P1CTL conferred partial protection, tumors recurred in almost all mice. Analysis of the status of the tumor antigen revealed that all J558 tumors underwent antigenic drift whereas all P815 tumors experienced antigenic loss. Interestingly, although Meth A cells are capable of both antigenic loss and antigenic drift, the majority of recurrent Meth A tumors retained P1A antigen. The ability of Meth A to induce apoptosis of P1CTL in vivo alleviated the need for antigenic drift and antigenic loss. Our data showed that, in spite of their shared tumor antigen, different lineages of cancer cells use different mechanisms to evade T-cell therapy.

CD24 on the Resident Cells of the Central Nervous System Enhances Experimental Autoimmune Encephalomyelitis

CD24 is a cell surface glycoprotein that is expressed on both immune cells and cells of the CNS. We have previously shown that CD24 is required for the induction of experimental autoimmune encephalomyelitis (EAE), an experimental model for the human disease multiple sclerosis (MS). The development of EAE requires CD24 expression on both T cells and non-T host cells in the CNS. To understand the role of CD24 on the resident cells in the CNS during EAE development, we created CD24 bone marrow chimeras and transgenic mice in which CD24 expression was under the control of a glial fibrillary acidic protein promotor (AstroCD24TG mice). We showed that mice lacking CD24 expression on the CNS resident cells developed a mild form of EAE; in contrast, mice with overexpression of CD24 in the CNS developed severe EAE. Compared with nontransgenic mice, the CNS of AstroCD24TG mice had higher expression of cytokine genes such as IL-17 and demyelination-associated marker P8; the CNS of AstroCD24TG mice accumulated higher numbers of Th17 and total CD4+ T cells, whereas CD4+ T cells underwent more proliferation during EAE development. Expression of CD24 in CD24-deficient astrocytes also enhanced their costimulatory activity to myelin oligodendrocyte glycoprotein-specific, TCR-transgenic 2D2 T cells. Thus, CD24 on the resident cells in the CNS enhances EAE development via costimulation of encephalitogenic T cells. Because CD24 is increased drastically on resident cells in the CNS during EAE, our data have important implications for CD24-targeted therapy of MS.

Targeting Activation Induced Cytidine Deaminase Promotes Rejection of Large Established Tumors by Cytotoxic T Lymphocytes in a Mouse Myeloma Model (50.8)

Activation induced cytidine deaminase (AID) is an essential enzyme that controls the generation of antibody diversity in B cells and is considered a general gene mutator. Using transgenic T cells specific to P1A (P1CTL) to treat mice with large established plasmacytoma J558 tumors, we frequently observed mutations in P1A antigenic epitope, which lead to cancer cell evasion of destruction by P1CTL. To determine whether AID plays a role in CTL-mediated rejection of plasmacytoma, we generated AID-silenced plasmacytoma J558 cells and controls and tested whether large established AID-silenced J558 tumors could be rejected by P1CTL. Complete rejection of large established tumors by P1CTL was rare (0–10%) in mice with AID+ J558 tumors while the rejection rates were 30–90% in mice with AID-silenced J558 tumors. AID knock down did not reduce mutation rate of P1A gene, but rather caused more genetic instability and altered gene expression profile. Notably, we observed strong up-regulation of OX-2 (CD200) gene and down-regulation of CaMKII-δ gene in AID-silenced J558 cells, whose roles may be related to enhanced immune rejection of AID-silenced J558 tumors. Our results suggest that simultaneously targeting AID in CTL-targeted therapy of myeloma or other AID+ tumors may be of therapeutic value.

Conception rates to artificial insemination in primiparous, suckled cows exposed to the biostimulatory effect of bulls before and during a gonadotropin-releasing hormone-based estrus synchronization protocol1,2

The objective of these studies was to evaluate whether exposing primiparous, suckled beef cows to the biostimulatory effect of bulls alters breeding performance associated with an estrus synchronization protocol that included GnRH followed 7 d later by PGF(2alpha) and fixed-time AI (TAI). This was a composite analysis of 3 experiments that evaluated (1) the effects of bull exposure at different days after calving (yr 1); (2) the biostimulatory effects of bull excretory products (yr 2); and (3) the biostimulatory effects of familiar and unfamiliar bulls (yr 3) on the resumption of ovarian cycling activity. In all studies, cows were exposed (biostimulated; n = 94) or not exposed (nonbiostimulated; n = 67) to bulls or excretory products of bulls for at least 60 d before the beginning of the estrus synchronization protocol. Average calving day did not differ among years and was 52 +/- 5 d. Year did not affect the proportions of biostimulated and nonbiostimulated cows that were cycling at the beginning of the estrus synchronization protocol; however, a greater (P < 0.001) proportion of biostimulated than nonbiostimulated cows were cycling at this time. In each year, cows were given GnRH followed by PGF(2alpha) 7 d later. Cows were observed for estrus twice daily (am and pm) after PGF(2alpha). Cows that exhibited estrus before 54, 60, and 64 h after PGF(2alpha) were inseminated by AI 12 h later in yr 1, 2, and 3, respectively. Cows that failed to show estrus were given GnRH and TAI at 62, 72, and 72 h after PGF(2alpha) in yr 1, 2, and 3, respectively. Conception rates were determined by transrectal ultrasonography 35 d after TAI in each year. The percentages of cows that exhibited estrus after PGF(2alpha) and before TAI, the interval from PGF(2alpha) to estrus, and the percentages of cows inseminated 12 h after estrus or at TAI did not differ between biostimulated and nonbiostimulated cows and were 51%, 54.7 +/- 7.3 h, 35%, and 65%, respectively. Conception rates for cows bred by AI 12 h after estrus did not differ between biostimulated and nonbiostimulated cows; however, the TAI conception rate was greater (P < 0.05) for biostimulated cows (57.6%) than for nonbiostimulated cows (35.6%). We conclude that TAI conception rates in an estrus synchronization protocol that includes GnRH followed 7 d later by PGF(2alpha) may be improved by the biostimulatory effect of bulls in postpartum, primiparous cows.

Initiation of postpartum luteal function in primiparous restricted-suckled beef cows exposed to a bull or excretory products of bulls or cows

The objective of this study was to evaluate the influence of bull excretory products on the resumption of postpartum luteal function in primiparous, restricted-suckled cows. Hypotheses tested were that resumption of luteal function or proportions of cows that initiate luteal cycling did not differ among cows exposed to a bull (BE), exposed to excretory products of bulls (EPB), not exposed to a bull (NE), or exposed to excretory products of cows (EPC). Two-year-old Angus x Hereford cows were assigned 35 d after calving to one of the four treatments (n = 15, 16, 16, and 15 for BE, EPB, NE, and EPC, respectively). Cows in the EPB and EPC treatments were placed in enclosures for 10 to 12 h, between 1830 and 0800 daily. Each enclosure was occupied by bulls (EPB) or left empty (EPC) for 10 to 12 h (0800 to 1830) daily. All cows were restricted to suckling twice daily (0800 and 1800) beginning on d 0. Blood samples were obtained from each cow on d -1 and every third day of the study thereafter. An increase in progesterone concentrations in three consecutive samples that exceeded 1.0 ng/mL was used as evidence of resumption of luteal function. Interval from d 0 to resumption of luteal activity was less for (P < 0.05) BE and EPB cows than for NE cows, but did not differ between BE and EPB cows. Interval for EPC cows did not differ from that for NE cows; however, interval for EPC cows was greater (P = 0.06) than that for BE cows and was longer (P < 0.05) than that of EPB cows. Proportions of cows that resumed luteal function by d 40 and 50 did not differ between NE and EPC cows; however, proportions of EPB and BE cows that resumed luteal function were greater (P < 0.05) than those for NE and EPC cows by d 40 and 50. Proportions of cows that resumed luteal function by d 70 were greater (P < 0.05) for BE, EPB, and EPC cows than for NE cows; however, proportions of BE and EPC cows did not differ. The proportion of EPB cows that resumed luteal function was greater (P = 0.058) than that of EPC cows, but the proportion of BE cows that resumed luteal function did not differ from that of EPC cows by d 70. We conclude that exposing primiparous restricted-suckled cows to excretory products of bulls or crowding estrus-cycling cows in an enclosure hastened postpartum resumption of luteal function. Therefore, the biostimulatory role of bulls and the crowding effect of cows seem to be mediated by a pheromone (or pheremones) present in their excretory products.

Cytokine-induced killer T cells kill immature dendritic cells by TCR-independent and perforin-dependent mechanisms

Cytokine-induced killer (CIK) cells are ex vivo, expanded T cells with proven anticancer activity in vitro and in vivo. However, their functional properties with the exception of their cancer cell-killing activity are largely unclear. Here, we show that CIK T cells recognize dendritic cells (DC), and although mature DC (mDC) induce CIK T cells to produce IFN-gamma, immature DC (iDC) are killed selectively by them. Moreover, CIK T cell activation by mDC and their destruction of iDC are independent of the TCR. The cytotoxicity of CIK T cells to iDC is perforin-dependent. Our data have revealed an important regulatory role of CIK cells.

Postpartum resumption of ovarian cycling activity in first-calf suckled beef cows exposed to familiar or unfamiliar bulls

The objective of this experiment was to determine if the proportion of first-calf suckled beef cows that resumed ovulatory cycles and the interval to resumption of ovarian cycling activity differ after exposure to either "unfamiliar" bulls or cows on d 35 postpartum, after exposure to either "familiar" bulls or cows for the first 30-32 d after calving. Fifty AngusxHereford cows were stratified by calving date, calf BW, and calf sex by d 3 postpartum, and assigned to be exposed to familiar epididectomized bulls (BEF; n=25) or familiar mature ovariectomized (OVX) cows (CEF; n=25). On d 35 after calving, 12 BEF cows were assigned to be exposed to unfamiliar bulls (BEU); likewise, 12 CEF cows were assigned to be exposed to unfamiliar OVX cows (CEU). Cows were in their treatments for either 95 d (BEF and CEF) or 60 d (BEU and CEU) during the experiment. Blood samples were collected every third d from the beginning to the end of the experiment. A rise in progesterone concentration of >0.5ng/mL in consecutive samples was used as the criterion for resumption of ovulatory cycles. Exposing cows to bulls on d 5 after calving and then switching a subset of these cows to be exposed to unfamiliar bulls 30-32 d later did not (P>0.10) alter: (1) the proportion of cows that resumed cycling activity; and (2) postpartum interval to resumption of ovarian cycling activity compared to cows exposed to familiar bulls. However, 32% more (P<0.05) cows exposed to bulls (BEF and BEU) resumed cycling activity by approximately 14.8 d before cows that were exposed to OVX cows (CEF and CEU). We conclude that the familiarity of first-calf cows to either bulls or ovariectomized cows, did not affect the postpartum occurrence of cycling activity or the interval from calving to resumption of ovulatory cycles. However, bull exposure, whether familiar or unfamiliar, stimulates first-calf cows to resume ovulatory cycles sooner after calving than if they are not exposed to bulls.

Introduction of bulls at different days postpartum on resumption of ovarian cycling activity in primiparous beef cows1

The objective of this study was to evaluate postpartum resumption of ovulatory cycles among primiparous, suckled beef cows that were exposed continuously to mature bulls beginning at various intervals after calving. We sought to determine whether cumulative distributions of proportions of cows resuming ovarian cycles and interval from the start of bull exposure to resumption of ovarian cycling activity differed among cows exposed continuously (BE) or not exposed (NE) to bulls beginning on d 15, 35, or 55 after calving. Angus x Hereford cows (n = 56) were assigned randomly to one of six treatments in a 2 (exposure type) x 3 (day exposed postpartum) factorial arrangement. Blood samples were collected from each cow starting on d -1, and every third day until the end of experiment. An increase in baseline progesterone concentrations that exceeded 1.0 ng/mL in three consecutive samples was used as evidence of resumption of ovarian cycling activity. More (P < 0.05) BE cows resumed cycling activity by the end of the experiment than NE cows. Proportions of cows resuming cycling activity did not differ (P = 0.30) among cows exposed to bulls on d 15, 35, or 55 postpartum. Proportions of BE cows that were exposed to bulls on d 15, 35, or 55 were greater for each 10-d interval (P < 0.05) than those for NE cows during the first 40 d after exposure. More (P < 0.05) BE cows exposed to bulls on d 55 resumed cycling activity by 30 d after exposure than BE cows exposed to bulls on either d 15 or 35. Interval from calving to resumption of cycling activity was decreased (P < 0.05) by the presence of bulls. Day of exposure did not affect (P = 0.21) interval from calving to resumption of cycling activity; however, interval from day of bull exposure to resumption of cycling activity decreased (P < 0.05) linearly as day of exposure to bulls after calving increased. We conclude that exposing primiparous beef cows to bulls decreased the postpartum anovulatory interval and increased the proportion of cows that exhibit resumption of ovarian cycling activity, independent of day of bull exposure. Furthermore, cows exposed to bulls at progressively later intervals postpartum seemed to respond more rapidly to the biostimulatory effect of bulls than when they were exposed earlier in the postpartum anestrous period.

CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis

In the development of experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS), autoreactive T cells must be activated and clonally expand in the lymphoid organs, and then migrate into the central nervous system (CNS) where they undergo further activation. It is unclear whether the autoreactive T cells further expand in the CNS and if so, what interactions are required for this process. We have demonstrated previously that expression by the host cells of the heat-stable antigen (CD24), which was recently identified as a genetic modifier for MS, is essential for their susceptibility to EAE. Here we show that CD24 is essential for local clonal expansion and persistence of T cells after their migration into the CNS, and that expression of CD24 on either hematopoietic cells or nonhematopoietic antigen-presenting cells in the recipient is sufficient to confer susceptibility to EAE.

Role of high speed biopsy gun in breast cancer diagnosis

Preoperative diagnosis of histology and receptor status is important in management of breast cancer. Percutaneous automated core biopsy with biopsy gun (Gun biopsy) was done in fifty patients with palpable breast lump in whom fine needle aspiration cytology (FNAC) was either negative or not done In all patients adequate tissue for histology and receptor status studies was obtained forty-two patients had infiltrating duct carcinoma and eight patients had benign lesions on gun biopsy. There were no complications in this procedure. Twenty of the forty-two patients underwent mastectomy either per primum or after chemotherapy, had the diagnosis substantiated on histopathological examination Thirty-four samples were examined for receptor status and the specimen was found to be adequate and of good quality. We conclude that gun biopsy is a simple and safe procedure which is more sensitive and specific than FNAC.

Acute neoplastic arterial embolism after pneumonectomy

Intra-arterial tumour embolism after pneumonectomy is a known but rare complication. It arises because of tumour involvement of pulmonary veins. Usual outcome of this complication is grave when embolism is to a major vessel. If embolism occurs in a peripheral circulation, timely intervention can avoid significant morbidity. We report a case where embolisation occurred in both the femoral arteries. Emergency embolectomy was done successfully avoiding major complication.

The mechanism of action of aspirin--is there anything beyond cyclo-oxygenase?

Aspirin, today, is an established drug in the regime for the prevention of myocardial infarction, especially in high-risk groups. This use of aspirin has given it a new lease of life in its tenth decade of clinical use. Aspirin is probably the oldest synthetic drug in the Pharmacopoeias today; thus one would have imagined that understanding about the drug would have reached a zenith and if not, that at least there should be certainty about its mechanism of action. Most workers agree that aspirin inhibits the cyclo-oxygenase enzyme in the platelets leading to reduced formation of prostaglandin G2, the precursor of thromboxanes. This explanation does not appear to be complete, since the role of the platelet activating factor (PAF) seems to have been ignored. The precursor for PAF is the lysophospholipid that is almost always formed when membrane phospholipid breakdown takes place. Any effective antiplatelet drug would have to inhibit the formation and/or the action of PAF, if it were to prevent platelet aggregation. Alternatively, the pathophysiological role attributed to PAF is highly exaggerated and needs to be reassessed.

Effect of vitamin A nutritional status on the growth of oestrogen-primed chick oviduct

Growth and development of the oestrogen-primed oviduct of immature chicks in terms of weight, length, total protein, total RNA, total DNA and total phospholipids are markedly arrested on deprivation of vitamin A; supplementation with retinyl acetate reversed the effect of the deficiency almost fully, whereas retinoic acid was only partly effective.

Vitamin A economy of the developing chick embryo and of the freshly hatched chick

1. The changes in the net amounts of retinol, retinyl esters and retinal in both the developing chick embryo and the newly hatched chick were investigated. The embryo requires about 68nmol of the vitamin for its growth, whereas the baby chick requires about 108nmol during the first 7 days after hatching. 2. Retinal was present in the egg in fairly high concentrations at the beginning of the incubation but it virtually disappeared from the extra-embryonic tissue after day 17 of incubation. It was not found in the liver of the embryo or of the newly hatched chick up until day 7.